Leukemia

Well rounded, clear and concise look at acute leukaemia.  

Learn how leukemia can be classified as an acute or chronic and myeloid or lymphoid disease. More free lessons at: http://www.khanacademy.org/video?v=frUCL0s...  

 

Chronic leukemias affect specialized blood cells that are partially through the process of maturation. Chronic lymphoblastic leukemias (CLL) often cause an e...  

Acute leukemias affect specialized blood cells at the most immature stage in their growth. Acute lymphoblastic leukemias (ALL) are the most common cancer in ...  

 

There are three main solutions to treat leukemia. Chemotherapy is a collection of drugs which target cells that rapidly multiply (a key characteristic in can...  

Myelodysplastic syndrome is sometimes referred to as "pre-leukemia" or a condition that occurs before leukemia (although most patients will never develop leu...  

Often health care professionals conduct a variety of blood tests to determine if someone has leukemia. Leukemia patients often have decreased levels of plate...  

USMLE Step Exam & ABIM Board Review Blog | Tips and strategies to pass the Internal Medicine Board Exam | Internal Medicine Flashcards | Medical Mnemonics  

Sometimes an immature blast cell have two gene mutations which prevent it from maturing into a specialized blood cell and cause it to multiply out of control...  

Leukemia is a collection of cancers which create a large amount of immature blood cells. These immature blood cells take up space in the bone marrow, prevent...  

Red Flags typically refer to features that may suggest serious life threatening disease such as malignancy (leukaemia), infection (septic arthritis or osteomyelitis) or non-accidental injury. We also include features that may suggest inflammatory joint or muscle disease.  

Two manufacturer sponsored phase III trials suggest that alemtuzumab, an anti-CD52 monoclonal antibody that is licensed to treat leukaemia, may help control multiple sclerosis. Both trials lasted two years and compared alemtuzumab with interferon beta-1a, which is considered first line treatment. One trial looked at 563 patients who had not yet undergone treatment for multiple sclerosis, whereas the other trial looked at …  

A grandfather with leukaemia, who was given just two years to live, is in remission after taking a new trial drug.  

“Leukemia cutis forearms Leukemia cutis: extensor forearms.”  

Visit http://www.DrNajeebLectures.com for 600+ videos on Basic Medical Sciences!  

Although cancer has an annual incidence of only about 150 new cases per 1 million U.S. children, it is the second leading cause of childhood deaths. Early detection and prompt therapy have the potential to reduce mortality. Leukemias, lymphomas and central nervous system tumors account for more than one half of new cancer cases in children. Early in the disease, leukemia may cause nonspecific symptoms similar to those of a viral infection. Leukemia should be suspected if persistent vague symptoms are accompanied by evidence of abnormal bleeding, bone pain, lymphadenopathy or hepatosplenomegaly. The presenting symptoms of a brain tumor may include elevated intracranial pressure, nerve abnormalities and seizures. A spinal tumor often presents with signs and symptoms of spinal cord compression. In children, lymphoma may present as one or more painless masses, often in the neck, accompanied by signs and symptoms resulting from local compression, as well as signs and symptoms of systemic disturbances, such as fever and weight loss. A neuroblastoma may arise from sympathetic nervous tissue anywhere in the body, but this tumor most often develops in the abdomen. The presentation depends on the local effects of the solid tumor and any metastases. An abdominal mass in a child may also be due to Wilms' tumor. This neoplasm may present with renal signs and symptoms, such as hypertension, hematuria and abdominal pain. A tumor of the musculoskeletal system is often first detected when trauma appears to cause pain and dysfunction out of proportion to the injury. Primary care physicians should be alert for possible presenting signs and symptoms of childhood malignancy, particularly in patients with Down syndrome or other congenital and familial conditions associated with an increased risk of cancer.